Search

Author/Creator Chain, Anne

2. Getting Innovative Therapies Faster to Patients at the Right Dose: Impact of Quantitative Pharmacology Towards First Registration and Expanding Therapeutic Use. Issue 3 (13th January 2018)

Authors:
Nayak, Satyaprakash; Sander, Oliver; Al‐Huniti, Nidal; de Alwis, Dinesh; Chain, Anne; Chenel, Marylore; Sunkaraneni, Soujanya; Agrawal, Shruti; Gupta, Neeraj; Visser, Sandra A.G.
Journal:
Clinical pharmacology & therapeutics
Issue:
Volume 103:Issue 3(2018)
Page Start:
378
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Immunogenicity of pembrolizumab in patients with advanced tumors. Issue 1 (8th August 2019)

Authors:
van Vugt, Marianne J. H.; Stone, Julie A.; De Greef, "Rik" H. J. M. M.; Snyder, Ellen S.; Lipka, Leslie; Turner, David C.; Chain, Anne; Lala, Mallika; Li, Mengyao; Robey, Seth H.; Kondic, Anna G.; De Alwis, Dinesh; Mayawala, Kapil; Jain, Lokesh; Freshwater, Tomoko
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 7:Issue 1(2019)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Impact of Low Birth Weight and Prematurity on Neonatal Raltegravir Pharmacokinetics: Impaact P1097. (15th December 2020)

Authors:
Clarke, Diana F.; Lommerse, Jos; Acosta, Edward P.; Cababasay, Mae P.; Wang, Jiajia; Spector, Stephen A.; Chain, Anne; Smith, Elizabeth; Teppler, Hedy; Hazra, Rohan; Calabrese, Kat; Graham, Bobbie; Popson, Stephanie; Bryson, Yvonne; Mirochnick, Mark
Journal:
Journal of acquired immune deficiency syndromes
Issue:
Volume 85:Number 5(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Maternal–Neonatal Raltegravir Population Pharmacokinetics Modeling: Implications for Initial Neonatal Dosing. (10th July 2019)

Authors:
Lommerse, Jos; Clarke, Diana; Kerbusch, Thomas; Merdjan, Henri; Witjes, Han; Teppler, Hedy; Mirochnick, Mark; Acosta, Edward P.; Wenning, Larissa; Nachman, Sharon; Chain, Anne
Journal:
CPT: pharmacometrics & systems pharmacology
Issue:
Volume 8:Number 9(2019)
Page Start:
643
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. P213 - A priori prediction of CYP3A victim drug-drug interaction of MK-1 and diltiazem using physiologically-based pharmacokinetic modeling (PBPK): qualification using clinical data. (2020)

Authors:
Gibson, Christopher; Hartmann, Georgy; Ma, Bennett; Chain, Anne; Smith, Sean; Forman, Mark; Datta, Sandip; Bateman, Thomas; Li, Ying; Khalilieh, Sauzanne
Journal:
Drug metabolism and pharmacokinetics
Issue:
Volume 35(2020)Supplement 1
Page Start:
S87
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Raltegravir (RAL) in Neonates: Dosing, Pharmacokinetics (PK), and Safety in HIV-1–Exposed Neonates at Risk of Infection (IMPAACT P1110). (1st May 2020)

Authors:
Clarke, Diana F.; Acosta, Edward P.; Cababasay, Mae; Wang, Jiajia; Chain, Anne; Teppler, Hedy; Popson, Stephanie; Graham, Bobbie; Smith, Betsy; Hazra, Rohan; Calabrese, Kat; Bryson, Yvonne; Spector, Stephen A.; Lommerse, Jos; Mirochnick, Mark
Journal:
Journal of acquired immune deficiency syndromes
Issue:
Volume 84:Number 1(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗